Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04985851
Brief Title: To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.

First Submitted : June 7, 2021
First Submitted that Met QC Criteria : July 27, 2021
First Posted : August 2, 2021

Last Update Submitted that Met QC Criteria : November 1, 2021
Last Update Posted : November 2, 2021